Clinical breast cancers receptor erbb 2. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Breast Cell Line, Tumor MCF-7 Cells Tumor Cells, Cultured Mammary Glands, Human Axilla Nipples Lymph Nodes Neoplastic Stem Cells Epithelial Cells Neoplastic Cells, Circulating Mammary Glands, Animal Cell Line

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases43

Breast Neoplasms Breast Diseases Carcinoma, Ductal, Breast Neoplasm Metastasis Neoplasm Invasiveness Uterine Cervical Neoplasms Breast Neoplasms, Male Carcinoma, Lobular Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease Mammary Neoplasms, Experimental Carcinoma Neoplasms, Hormone-Dependent Ovarian Neoplasms Lymphatic Metastasis Neoplasm Recurrence, Local Lung Neoplasms Fibrocystic Breast Disease Neoplasms Disease Progression Prostatic Neoplasms Bone Neoplasms Cell Transformation, Neoplastic Colonic Neoplasms Carcinoma, Ductal Stomach Neoplasms Carcinoma in Situ Neoplasms, Second Primary Triple Negative Breast Neoplasms Inflammatory Breast Neoplasms Adenocarcinoma Pancreatic Neoplasms Fibroadenoma Neoplastic Cells, Circulating Neovascularization, Pathologic Neoplasms, Basal Cell Colorectal Neoplasms Neoplasms, Radiation-Induced Endometrial Neoplasms Neoplasms, Multiple Primary Carcinoma, Squamous Cell Mammary Neoplasms, Animal Carcinoma, Non-Small-Cell Lung

Chemicals and Drugs56

Neuregulin-1 Neuregulins Receptor, erbB-3 Receptors, Estrogen Receptor, erbB-2 Receptor, Epidermal Growth Factor Epidermal Growth Factor Tamoxifen Receptors, Progesterone Tumor Markers, Biological Antineoplastic Agents, Hormonal Antineoplastic Agents Neoplasm Proteins Estrogen Receptor alpha Estrogens RNA, Messenger BRCA2 Protein BRCA1 Protein Aromatase Inhibitors Estrogen Antagonists DNA, Neoplasm RNA, Small Interfering Antibodies, Monoclonal, Humanized Estradiol Fluorouracil Estrogen Receptor Modulators Antibodies, Monoclonal Cyclophosphamide Epirubicin Selective Estrogen Receptor Modulators Nitriles Tumor Suppressor Protein p53 Oncogene Proteins v-erbB Tumor Suppressor Proteins Paclitaxel Ki-67 Antigen RNA, Neoplasm Antigens, Neoplasm Cancer Vaccines Quinazolines Proto-Oncogene Proteins c-akt Anticarcinogenic Agents Transcription Factors Antigens, CD24 Triazoles Proto-Oncogene Proteins Mucin-1 Antibiotics, Antineoplastic MicroRNAs DNA-Binding Proteins Anthracyclines Cyclin D1 Phosphatidylinositol 3-Kinases Protein-Serine-Threonine Kinases Protein Kinase Inhibitors Doxorubicin

Analytical, Diagnostic and Therapeutic Techniques and Equipment79

Breast Self-Examination Mammography Palpation Early Detection of Cancer Physical Examination Mass Screening Prognosis Risk Factors Vaginal Smears Sensitivity and Specificity Neoplasm Staging Papanicolaou Test Mastectomy Questionnaires Chemotherapy, Adjuvant False Positive Reactions Mammary Neoplasms, Experimental Logistic Models Antineoplastic Combined Chemotherapy Protocols Survival Analysis Case-Control Studies Immunohistochemistry Gene Expression Profiling Disease-Free Survival Risk Cross-Sectional Studies Follow-Up Studies Reverse Transcriptase Polymerase Chain Reaction Survival Rate Prospective Studies Risk Assessment Retrospective Studies Mastectomy, Segmental Odds Ratio Incidence Blotting, Western Xenograft Model Antitumor Assays Treatment Outcome Cohort Studies Multivariate Analysis Registries Neoplasm Transplantation Oligonucleotide Array Sequence Analysis Transplantation, Heterologous Ultrasonography, Mammary Magnetic Resonance Imaging Tissue Array Analysis Tumor Burden Kaplan-Meier Estimate SEER Program Predictive Value of Tests Transfection Breast Implants Combined Modality Therapy Reproducibility of Results Polymerase Chain Reaction Neoplasm Grading Immunoenzyme Techniques Radiotherapy, Adjuvant Mammaplasty Confidence Intervals Clinical Trials as Topic Neoadjuvant Therapy Molecular Targeted Therapy Drug Screening Assays, Antitumor Genetic Testing Proportional Hazards Models Drug Administration Schedule In Situ Hybridization, Fluorescence Sentinel Lymph Node Biopsy Radiotherapy Biopsy, Needle Estrogen Replacement Therapy Gene Knockdown Techniques Biopsy Models, Biological Lymph Node Excision DNA Mutational Analysis Mastectomy, Radical

Psychiatry and Psychology4

Breast Self-Examination Health Knowledge, Attitudes, Practice Breast Feeding Health Behavior

Phenomena and Processes50

Gene Expression Regulation, Neoplastic Genes, erbB Sensitivity and Specificity Genes, BRCA1 Postmenopause Genes, erbB-2 Drug Resistance, Neoplasm Genetic Predisposition to Disease Breast Feeding Cell Proliferation Premenopause Risk Signal Transduction Menopause Genes, BRCA2 Odds Ratio Mutation Apoptosis Cell Movement Cell Division Time Factors Down-Regulation Genotype Gene Amplification Germ-Line Mutation Transfection Cell Growth Processes Phosphorylation Promoter Regions, Genetic Polymorphism, Genetic DNA Methylation Cell Cycle RNA Interference Up-Regulation Dose-Response Relationship, Drug Cell Survival Gene Expression Parity Gene Silencing Base Sequence Phenotype Genes, Neoplasm Genes, Tumor Suppressor Epithelial-Mesenchymal Transition Genes, p53 Alleles Heterozygote Drug Synergism Diet Transcription, Genetic

Disciplines and Occupations2

Immunohistochemistry Medical Oncology

Anthropology, Education, Sociology and Social Phenomena3

Socioeconomic Factors Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science7

Questionnaires Survival Rate Incidence Registries SEER Program Base Sequence Molecular Sequence Data

Named Groups3

Survivors European Continental Ancestry Group African Americans

Health Care35

Mass Screening Risk Factors Sensitivity and Specificity Health Knowledge, Attitudes, Practice Questionnaires Logistic Models Survival Analysis Case-Control Studies Disease-Free Survival Risk Cross-Sectional Studies Follow-Up Studies Survival Rate Prospective Studies Risk Assessment Retrospective Studies Age Factors Odds Ratio Patient Acceptance of Health Care Socioeconomic Factors Incidence Treatment Outcome Cohort Studies Multivariate Analysis Registries Kaplan-Meier Estimate SEER Program Predictive Value of Tests Reproducibility of Results Confidence Intervals Clinical Trials as Topic Parity Genetic Testing Proportional Hazards Models National Cancer Institute (U.S.)

Geographicals2

United States China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Breast Neoplasms Neuregulin-1 Neuregulins Receptor, erbB-3 Receptors, Estrogen Breast Self-Examination Mammography Receptor, erbB-2 Breast Gene Expression Regulation, Neoplastic Cell Line, Tumor Palpation Receptor, Epidermal Growth Factor Early Detection of Cancer Physical Examination Mass Screening Breast Diseases Carcinoma, Ductal, Breast Epidermal Growth Factor Genes, erbB Prognosis Tamoxifen Receptors, Progesterone Risk Factors Neoplasm Metastasis Neoplasm Invasiveness Uterine Cervical Neoplasms Tumor Markers, Biological Vaginal Smears Breast Neoplasms, Male Antineoplastic Agents, Hormonal United States Sensitivity and Specificity Health Knowledge, Attitudes, Practice Antineoplastic Agents Neoplasm Staging Papanicolaou Test Mastectomy Neoplasm Proteins Genes, BRCA1 Questionnaires Postmenopause Chemotherapy, Adjuvant Carcinoma, Lobular MCF-7 Cells False Positive Reactions Mice, Nude Tumor Cells, Cultured Genes, erbB-2 Carcinoma, Intraductal, Noninfiltrating Drug Resistance, Neoplasm Genetic Predisposition to Disease Mammary Neoplasms, Experimental Logistic Models Breast Feeding Estrogen Receptor alpha Cell Proliferation Antineoplastic Combined Chemotherapy Protocols Carcinoma Survival Analysis Premenopause Estrogens Case-Control Studies Immunohistochemistry Gene Expression Profiling Neoplasms, Hormone-Dependent Disease-Free Survival Ovarian Neoplasms Lymphatic Metastasis Risk Cross-Sectional Studies Follow-Up Studies Neoplasm Recurrence, Local Reverse Transcriptase Polymerase Chain Reaction Signal Transduction Health Behavior Menopause RNA, Messenger BRCA2 Protein Survival Rate Genes, BRCA2 BRCA1 Protein Prospective Studies Lung Neoplasms Fibrocystic Breast Disease Aromatase Inhibitors Estrogen Antagonists Risk Assessment Neoplasms Mammary Glands, Human Disease Progression Survivors Retrospective Studies Age Factors Mastectomy, Segmental Axilla Odds Ratio Patient Acceptance of Health Care Socioeconomic Factors Prostatic Neoplasms

No FAQ available that match "clinical breast cancers receptor erbb 2"